SCHEMBL8685707

SCHEMBL8685707

c1ccc(-c2cnn3cc[nH]c23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
PIM1 P11309 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CCNK O75909 1/20 0.35
CDK12 Q9NYV4 1/20 0.35
RET P07949 2/20 0.35
ACVR1 Q04771 2/20 0.35
PLAT P00750 1/20 0.35
TGFBR1 P36897 1/20 0.35
PRKAB1 Q9Y478 1/20 0.35
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
LMNA P02545 1/20 0.34
IKBKB O14920 1/20 0.34
CHUK O15111 1/20 0.34
DAPK3 O43293 1/20 0.34
JAK2 O60674 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9591318 0.78 IDO1 (0.37) NPC1RAB9AMEN1KMT2ACCNK
SCHEMBL3788643 0.71 PLAT (0.43) NPC1RAB9AMEN1KMT2APLAT
SCHEMBL18160954 0.68 CAMKK1 (0.50) KDRNPC1RAB9APIM1MEN1
SCHEMBL6279830 0.66 KDM4E (0.39) KDRNPC1RAB9AMEN1KMT2A
SCHEMBL1614285 0.64 KDR (0.39) KDRNPC1RAB9APIM1MEN1
SCHEMBL1659942 0.64 KDR (0.39) KDRNPC1RAB9APIM1MEN1
SCHEMBL7112314 0.64 KDR (0.59) KDRNPC1RAB9APIM1MEN1
SCHEMBL15286421 0.63 CAMKK1 (0.56) KDRNPC1RAB9APIM1MEN1
SCHEMBL10508644 0.59 HIF1A (0.53) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL12175373 0.58 CREBBP (0.62) NPC1RAB9AMEN1KMT2AAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665752-A LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-09-09 US claimed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 EP claimed
EP-0353047-A2 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents Sankyo Company Limited (JP) 1990-01-31 EP claimed
US-5723481-A ANTIULCER AGENTS AND 5-LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-03-03 US disclosed
US-5698576-A POSSESS ANTI-ULCER AND 5-LIPOXYGENASE INHIBITORY ACTIVITIES SANKYO COMPANY, LIMITED (JP) 1997-12-16 US disclosed
US-5665752-A LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-09-09 US disclosed
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 US disclosed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 EP disclosed
US-5232939-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY LIMITED (JP) 1993-08-03 US disclosed
EP-0353047-A2 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents Sankyo Company Limited (JP) 1990-01-31 EP disclosed